Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie McCormick

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Arthritis Care & Research|August 27, 2016
Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011Sharan K Rai, J Antonio Aviña-Zubieta, Natalie McCormick, et al.
Seminars in Arthritis and Rheumatism|January 2, 2017
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012Sharan K Rai, J Antonio Aviña-Zubieta, Natalie McCormick, et al.
Arthritis Care & Research|July 7, 2025
Long-term lignan intake, whole grain foods, and the risk of gout: results from two prospective cohort studiesSharan K Rai, Yang Hu, Ming Ding, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 2, 2019
Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort studyChio Yokose, Na Lu, Hui Xie, et al.
Annals of Internal Medicine|January 16, 2023
Hydroxychloroquine Dose and Risk for Incident Retinopathy : A Cohort StudyRonald B Melles, April M Jorge, Michael F Marmor, et al.
The Lancet. Rheumatology|December 21, 2024
Cardiovascular events in patients with gout initiating urate-lowering therapy with or without colchicine for flare prophylaxis: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality dataEdoardo Cipolletta, Georgina Nakafero, Natalie McCormick, et al.
JAMA Internal Medicine|April 15, 2024
Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving MetforminNatalie McCormick, Chio Yokose, Na Lu, et al.
Annals of Internal Medicine|July 24, 2023
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort StudyNatalie McCormick, Chio Yokose, Jie Wei, et al.
Annals of Internal Medicine|January 24, 2022
Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort StudyJie Wei, Hyon K Choi, Tuhina Neogi, et al.
Rheumatology (Oxford, England)|October 11, 2022
Nationwide racial/ethnic disparities in US emergency department visits and hospitalizations for goutChio Yokose, Natalie McCormick, Na Lu, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Arthritis Care & Research|August 27, 2016
Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011Sharan K Rai, J Antonio Aviña-Zubieta, Natalie McCormick, et al.
Seminars in Arthritis and Rheumatism|January 2, 2017
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012Sharan K Rai, J Antonio Aviña-Zubieta, Natalie McCormick, et al.
Arthritis Care & Research|July 7, 2025
Long-term lignan intake, whole grain foods, and the risk of gout: results from two prospective cohort studiesSharan K Rai, Yang Hu, Ming Ding, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 2, 2019
Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort studyChio Yokose, Na Lu, Hui Xie, et al.
Annals of Internal Medicine|January 16, 2023
Hydroxychloroquine Dose and Risk for Incident Retinopathy : A Cohort StudyRonald B Melles, April M Jorge, Michael F Marmor, et al.
The Lancet. Rheumatology|December 21, 2024
Cardiovascular events in patients with gout initiating urate-lowering therapy with or without colchicine for flare prophylaxis: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality dataEdoardo Cipolletta, Georgina Nakafero, Natalie McCormick, et al.
JAMA Internal Medicine|April 15, 2024
Sodium-Glucose Cotransporter-2 Inhibitors vs Sulfonylureas for Gout Prevention Among Patients With Type 2 Diabetes Receiving MetforminNatalie McCormick, Chio Yokose, Na Lu, et al.
Annals of Internal Medicine|July 24, 2023
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort StudyNatalie McCormick, Chio Yokose, Jie Wei, et al.
Annals of Internal Medicine|January 24, 2022
Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort StudyJie Wei, Hyon K Choi, Tuhina Neogi, et al.
Rheumatology (Oxford, England)|October 11, 2022
Nationwide racial/ethnic disparities in US emergency department visits and hospitalizations for goutChio Yokose, Natalie McCormick, Na Lu, et al.
Pageof 6